The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

…, WP Maksymowych, H Mielants, IJ Sørensen… - Annals of the …, 2009 - ard.bmj.com
Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis
of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international …

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO …

B Glintborg, IJ Sørensen, AG Loft… - Annals of the …, 2017 - ard.bmj.com
Objectives According to guidelines, a nationwide non-medical switch from originator (INX,
Remicade) to biosimilar infliximab (Remsima, CT-P13) was conducted in Danish patients with …

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 …

…, IMJ Hansen, DD Pedersen, IJ Sørensen… - Annals of the …, 2019 - ard.bmj.com
Objectives Real-world evidence on effectiveness of switching to biosimila r etanercept is
scarce. In Denmark, a nationwide guideline of mandatory switch from 50 mg originator (ETA) to …

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

M Faurschou, IJ Sorensen, L Mellemkjaer… - The Journal of …, 2008 - jrheum.org
OBJECTIVE: To describe the incidence of malignancies in a cohort of Danish patients with
Wegener's granulomatosis (WG) and to investigate the cancer risk associated with …

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis …

SJ Pedersen, IJ Sørensen, P Garnero… - Annals of the …, 2011 - ard.bmj.com
Objectives To investigate the relation between ankylosing spondylitis disease activity score (ASDAS),
Bath ankylosing spondylitis disease activity index (BASDAI) and treatment …

Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe'whole-body MRI and clinical examination

…, I Eshed, M Østergaard, IJ Sørensen… - Annals of the …, 2015 - ard.bmj.com
Objectives To investigate the ability of whole-body MRI (WBMRI) to detect axial and peripheral
enthesitis in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), and …

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of …

SJ Pedersen, IJ Sørensen, KGA Hermann… - Annals of the …, 2010 - ard.bmj.com
Objectives To investigate construct validity and responsiveness of the novel ankylosing
spondylitis (AS) disease activity score (ASDAS) in patients with spondyloarthritis (SpA). Methods …

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis

…, L Mellemkjaer, IJ Sorensen… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Experimental studies indicate that patients with Wegener's granulomatosis (WG)
experience accelerated atherosclerosis. The purpose of this study was to investigate whether …

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a …

SJ Pedersen, IJ Sørensen, RGW Lambert… - Arthritis & …, 2011 - Wiley Online Library
Objective To investigate the relationship of circulating biomarkers of inflammation (C‐reactive
protein [CRP], interleukin‐6 [IL‐6], and YKL‐40), angiogenesis (vascular endothelial …

Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral …

…, SJ Pedersen, I Eshed, IJ Sørensen… - …, 2015 - academic.oup.com
Objectives. By whole-body MRI (WBMRI), we aimed to examine the frequency and distribution
of inflammatory and structural lesions in PsA patients, SpA patients and healthy subjects (…